Hi, my name is Sukjun Kim. I am a computational biologist and a biomedical data scientist with a keen interest in developing biomarkers to predict cancer patients’ treatment outcomes. My passion lies in tackling challenges within cancer genomics, RNA biology, and digital pathology using the power of artificial intelligence. Welcome to my personal blog, where I share my experiences and thoughts. Thank you for visiting, and I hope you find the content insightful and engaging.
Sukjun Kim, Seulki Kim, Yoojoo Lim, Gahee Park, Sanghoon Song, Heon Song, Seonwook Park, Jeongun Ryu, Sergio Pereira, Donggeun Yoo, Kyunghyun Paeng, Chan-Young Ock. Spatial analysis of tumor-infiltrating lymphocytes (TILs) based on HER2 expression across multiple cancer types. Society for Immunotherapy of Cancer (2022).
Jimin Moon, Hyung-Gyo Cho, Seokhwi Kim, Sukjun Kim, Gahee Park, Sanghoon Song, Wonkyung Jung, Chan-Young Ock. Multimodal approach to discover novel targets for antibody-drug conjugates by analyzing distinct expression patterns of frequent copy number aberration. European Society for Medical Oncology (2022).
Jeong Hwan Park, Soo Ick Cho, Kyu Sang Lee, Euno Choi, Wonkyung Jung, Sukjun Kim, Gahee Park, Sanghoon Song, Cholmin Kang, Minuk Ma, Donggeun Yoo, Kyunghyun Paeng, Chan-Young Ock. Performance validation of an artificial intelligence-powered Programmed death-ligand 1 (PD-L1) combined positive score analyzer in urothelial cancer. European Society for Medical Oncology (2022).
Seokhwi Kim, Gahee Park, Sukjun Kim, Sanghoon Song, Heon Song, Jeongun Ryu, Seonwook Park, Sergio Pereira, Kyunghyun Paeng, Chan-Young Ock. Artificial intelligence-powered tumor purity assessment from H&E whole slide images associates with variant allele frequency of somatic mutations across 23 cancer types in TCGA cohorts. European Society for Medical Oncology (2022).
Gahee Park, Sanghoon Song, Sukjun Kim, Sangheon Ahn, Hyunjoo Kim, Jaegeun Lee, Juneyoung Ro, Woomin Park, Taiwon Chung, Cholmin Kang, Chunggi Lee, Huijeong Kim, Jisoo Shin, Seungje Lee, Eunji Baek, Sumin Lee, Melody SeungHui Seo, Hyojung Choi, Donggeun Yoo, Chan-Young Ock. Artificial intelligence-powered pathology image analysis merged with spatial transcriptomics reveals distinct TIGIT expression in the immune-excluded tumor-infiltrating lymphocytes. American Society of Clinical Oncology (2022).
Doyeon Kim, Sukjun Kim, Joori Park, Hee Ryung Chang, Jeeyoon Chang, Junhak Ahn, Heedo Park, Junehee Park, Narae Son, Gihyeon Kang, Jeonghun Kim, Kisoon Kim, Man-Seong Park, Yoon Ki Kim, Daehyun Baek. A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome. Nature Communications 12, 5120 (2021).
Sukjun Kim, Soyoung Kim, Hee Ryung Chang, Doyeon Kim, Junehee Park, Narae Son, Joori Park, Minhyuk Yoon, Gwangung Chae, Young-Kook Kim, V. Narry Kim, Yoon Ki Kim, Jin-Wu Nam, Chanseok Shin, Daehyun Baek. The regulatory impact of RNA-binding proteins on microRNA targeting. Nature Communications 12, 5057 (2021).
Doyeon Kim, You Me Sung, Jinman Park, Sukjun Kim, Jongkyu Kim, Junhee Park, Haeok Ha, Jung Yoon Bae, SoHui Kim and Daehyun Baek. General rules for functional microRNA targeting. Nature Genetics 48, 1517-26 (2016).
Seongmin Choi, Hyeong Ryul Kim, Chang Ohk Sung, Jongkyu Kim, Sukjun Kim, …, Gu Kong, Daehyun Baek, and Se Jin Jang (2015). Genomic alterations in the RB pathway indicate prognostic outcomes of early-stage lung adenocarcinoma. Clinical Cancer Research 21(11), 2613-23 (2015).
Sung-Min Ahn, Se Jin Jang, Ju Hyun Shim, …, Daehyun Baek, Farhan Haq, Adnan Ahmed Ansari, Sun Young Lee, Sung-Min Chun, Seongmin Choi, Hyun-Jeung Choi, Jongkyu Kim, Sukjun Kim, … and Gu Kong (2014). Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification. Hepatology 60(6), 1972-82 (2014).